Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia [Phase 3]
Phase 3 trial assessing the efficacy and safety of Raphamin in combination therapy for community-acquired pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia [Phase 4]
This Phase 4 trial update discusses a shortened 5-day antibiotic course for treating community-acquired pneumonia.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study [NA]
This pediatric trial compares placebo to a macrolide antibiotic for Mycoplasma pneumoniae pneumonia within community-acquired pneumonia in c…
-
CLINICAL_TRIALS withdrawal · 2025-03-28Clinical Trial Update: A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS [Phase 2]
The Phase 2 pharmacokinetics and safety study of Augmentin ES-600 in children with community-acquired pneumonia and acute bacterial rhinosin…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: The Association Mechanism Between the Microbiome and the Development of Community Pneumonia Was Studied Based on the Analysis of Pulmonary Microbiota - Host Interaction Network
A clinical trial update detailing research on how the pulmonary microbiome and host interactions influence the development of community-acqu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia [Phase 3]
Phase 3 clinical trial is assessing customized antibiotic treatment duration for hospitalized patients with moderately severe community-acqu…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Local Antibiotic Delivery for Community Acquired Pneumonia [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating local antibiotic delivery for community-acquired pneumonia, with recruitment not yet started.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP [Phase 3]
Phase 3 trial evaluating betamethasone therapy in hospitalized children with community-acquired pneumonia has completed.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit
A clinical trial sponsored by the Chinese University of Hong Kong is evaluating the prevalence of Streptococcus pneumoniae serotypes using a…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older
Pfizer-sponsored completed trial evaluating the effectiveness of PCV13 against vaccine-type pneumococcal hospitalised community-acquired pne…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Clinical Impact of a Multiplex Rapid Diagnostic Pneumonia Panel Testing in Critically-ill Patients With Severe Hospital-acquired Pneumonia, Ventilator-associated Pneumonia and Community-acquired Pneumonia With High Risk of Multidrug Resistant Pathogen [NA]
This clinical trial update evaluates the impact of a multiplex rapid diagnostic pneumonia panel in critically ill patients with severe hospi…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia
A recruiting clinical trial sponsored by ARCIM Institute is studying antibiotic prescription practices for children hospitalized with commun…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: How Does Medical Clown Intervention Affect the Length of Hospitalization in Children With Pneumonia [NA]
A completed clinical trial evaluated whether a medical clown intervention reduces length of hospital stay in children with community-acquire…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia [NA]
A clinical trial registry entry for Fei Re Qing Granules in elderly patients with community-acquired pneumonia, currently not yet recruiting…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy [Phase 4]
Clinical trial update for a Phase 4 study to optimize short-course antibiotic therapy in children hospitalized with community-acquired pneum…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel Diagnostics [NA]
A clinical trial is evaluating novel diagnostic approaches to improve care for children hospitalized with community-acquired pneumonia, and …
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Predictors of Improvement and Deterioration of Community Acquired Pneumonia in Children
A clinical trial at Assiut University is investigating predictors of improvement and deterioration in community-acquired pneumonia in childr…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Targeting Vascular INflammation in Patients with Community-Acquired Pneumonia [Phase 3]
Phase 3 clinical trial update for Targeting Vascular Inflammation in Patients with Community-Acquired Pneumonia; the study is currently not …
-
FDA approval · 2024-12-04FDA Approved: DOXYCYCLINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's generic doxycycline as an original ANDA product.
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Clinical Characteristics and Outcome of Patients With Community Acquired Pneumonia
The study aims to characterize the clinical characteristics and outcomes of patients with community-acquired pneumonia, with status not yet …
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice [NA]
A completed clinical trial from Aalborg University assessing whether focused lung ultrasonography in general practice influences antibiotic …
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: The Effect of Adjunct Vitamin a on Community-Acquired Pneumonia in Southern Iranian Children: a Randomized Clinical Trial [NA]
A completed randomized clinical trial evaluated whether adding Vitamin A to standard care affects outcomes in children with community-acquir…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Electrical Impedance Imaging Techniques in Guiding the Use of Chest Physiotherapy in Patients with Pneumonia [NA]
Completed clinical trial evaluating electrical impedance imaging to guide the use of chest physiotherapy in patients with community-acquired…
-
FDA approval · 2024-10-28FDA Approved: DOXYCYCLINE — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' generic doxycycline as an Original Application (ANDA 218053), enabling market entry of a doxycycl…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 [Phase 1]
A first-in-human Phase 1 study of CMTX-101 in pneumonia was terminated, with no completed safety, tolerability, pharmacokinetics, or immunog…